Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.

Journal of pharmacy practice(2023)

Cited 1|Views11
No score
Abstract
Tocilizumab did not appear to influence clinical outcomes in our study population, irrespective of timing of administration. Adverse events were not considered drug-related.
More
Translated text
Key words
COVID-19,cytokine release syndrome,cytokine storm,interleukin-6 receptor antagonist,tocilizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined